{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:39:33Z","timestamp":1787841573295,"version":"build-2784847793"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>The administration of intravenous thrombolysis (IVT) for patients with acute ischemic stroke who have recently ingested direct oral anticoagulants (DOACs) presents a clinical challenge due to the perceived increased risk of intracranial hemorrhage (ICH). Traditional guidelines from the US and European authorities advise against IVT within 48 h of last DOAC ingestion, unless specific coagulation tests indicate safety. However, emerging observational studies suggest that IVT might be safe in selected patients. A US stroke registry study and a global multicenter cohort study both reported no significant increase in symptomatic ICH among patients on DOACs compared to those not on anticoagulants. A systematic review of all published observational studies further supported these findings, showing comparable bleeding rates and functional outcomes in DOAC-treated patients. Reversal agents like idarucizumab for dabigatran have demonstrated potential in facilitating safer IVT administration, though logistical and cost-related barriers limit their widespread use. The variability in global guidelines reflects differing approaches to risk assessment and resource availability, highlighting the need for individualized treatment decisions. In India, the increasing prevalence of atrial fibrillation and stroke as well as prescription of DOACs necessitate adapted guidelines that consider local health-care infrastructure. Despite the promising observational data, the lack of randomized controlled trials underscores the need for further research to establish robust evidence for IVT use in this context. Collaborative international efforts and inclusion of diverse patient populations in future studies will be crucial to refine treatment protocols and improve outcomes for stroke patients on DOACs.<\/jats:p>","DOI":"10.4103\/aian.aian_524_24","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T11:03:57Z","timestamp":1724151837000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants \u2013 A Growing Dilemma Also in India"],"prefix":"10.4103","volume":"27","author":[{"given":"Thomas R.","family":"Meinel","sequence":"first","affiliation":[{"name":"Department of Neurology and Stroke Research Center, Bern Inselspital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen K.","family":"Paramasivan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijoy K.","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Radiology and Community Health Sciences, Cumming School of Medicine and the Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke Research Center, Bern Inselspital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Seiffge","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke Research Center, Bern Inselspital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke A","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"R4-20260427","article-title":"ISA: Consensus statement recommendations for the early management of acute ischemic stroke: A consensus statement for healthcare professionals from the Indian Stroke Association"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"102456","DOI":"10.1016\/j.cpcardiol.2024.102456","article-title":"Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry","volume":"49","author":"Chen","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/ijabmr.ijabmr_135_21","article-title":"Cross-sectional survey of anticoagulant use among specialist physicians with a focus on direct anticoagulants","volume":"11","author":"Singh","year":"2021","journal-title":"Int J Appl Basic Med Res"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"e026723","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vhri.2022.04.007","article-title":"Cost-utility analysis of dabigatran and warfarin for stroke prevention among patients with nonvalvular atrial fibrillation in India","volume":"31","author":"Aghoram","year":"2022","journal-title":"Value Health Reg Issues"},{"key":"R9-20260427","first-page":"43","article-title":"Cost-effectiveness of apixaban versus other oral anticoagulants and aspirin for stroke prevention in atrial fibrillation in Indian subcontinent","author":"Kulkarni","year":"2022","journal-title":"Eur Heart J"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/jpgm.jpgm_10_23","article-title":"Trends in oral anticoagulant use-A 10-year retrospective analysis from a general medicine department of a tertiary care hospital in south India","volume":"70","author":"Thomas","year":"2024","journal-title":"J Postgrad Med"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann Neurol"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jama.2022.0948","article-title":"Association of recent use of non\u2013Vitamin K antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase","volume":"327","author":"Kam","year":"2022","journal-title":"JAMA"},{"key":"R14-20260427","first-page":"23969873241252751","article-title":"Intravenous thrombolysis in patients with recent intake of direct oral anticoagulants: A target trial analysis after the liberalization of institutional guidelines","volume":"2024","author":"B\u00fccke","journal-title":"Eur Stroke J"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/europace\/euz141","article-title":"Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: The FAI Project","volume":"21","author":"Di Carlo","year":"2019","journal-title":"Europace"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/heartasia-2015-010674","article-title":"Prevalence of atrial fibrillation in an urban population in India: The Nagpur pilot study","volume":"8","author":"Saggu","year":"2016","journal-title":"Heart Asia"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ihj.2022.02.002","article-title":"Prevalence, clinical profile, and stroke risk of atrial fibrillation in rural Andhra Pradesh, India (the AP-AF study)","volume":"74","author":"Saggu","year":"2022","journal-title":"Indian Heart J"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2018.12.016","article-title":"Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study","volume":"280","author":"Soni","year":"2019","journal-title":"Int J Cardiol"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/jcbfm.2013.226","article-title":"Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke","volume":"34","author":"Ploen","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1160\/TH12-12-0942","article-title":"Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia","volume":"110","author":"Sun","year":"2013","journal-title":"Thromb Haemost"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ana.23558","article-title":"Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke","volume":"71","author":"Pfeilschifter","year":"2012","journal-title":"Ann Neurol"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/STROKEAHA.110.604652","article-title":"Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: An experimental study in mice","volume":"42","author":"Pfeilschifter","year":"2011","journal-title":"Stroke"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"e025809","DOI":"10.1161\/JAHA.122.025809","article-title":"Intravenous thrombolysis with alteplase at 0.6 mg\/kg in patients with ischemic stroke taking direct oral anticoagulants","volume":"11","author":"Okada","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamainternmed.2023.6160","article-title":"Risk of bleeding following non-vitamin K antagonist oral anticoagulant use in patients with acute ischemic stroke treated with alteplase","volume":"184","author":"Tsai","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R25-20260427","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamaneurol.2022.4782","article-title":"Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants","volume":"80","author":"Meinel","year":"2023","journal-title":"JAMA Neurol"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jama.2023.0550","article-title":"Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: The ARAIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"R27-20260427","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/1747493020978345","article-title":"The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods","volume":"16","author":"Deeds","year":"2021","journal-title":"Int J Stroke"},{"key":"R28-20260427","doi-asserted-by":"crossref","first-page":"e031669","DOI":"10.1161\/JAHA.123.031669","article-title":"Intravenous thrombolysis for acute ischemic stroke in patients with recent direct oral anticoagulant use: A systematic review and meta-analysis","volume":"12","author":"Ghannam","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/cjn.2022.344","article-title":"Canadian stroke best practice recommendations: Acute stroke management, 7th edition practice guidelines update, 2022","volume":"51","author":"Heran","year":"2024","journal-title":"Can J Neurol Sci"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2176\/nmc.st.2019-0177","article-title":"Guidelines for intravenous thrombolysis (Recombinant tissue-type plasminogen activator), the third edition, March 2019: A guideline from the Japan stroke society","volume":"59","author":"Toyoda","year":"2019","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R31-20260427","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp-2020-325456","article-title":"Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"92","author":"Seiffge","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1747493016659671","article-title":"Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?","volume":"11","author":"Drouet","year":"2016","journal-title":"Int J Stroke"},{"key":"R33-20260427","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021 update of the International Council for Standardization in haematology recommendations for laboratory measurement of direct oral anticoagulants","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemost"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"},{"key":"R35-20260427","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: A systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"R36-20260427","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/STROKEAHA.116.014963","article-title":"Coagulation testing in acute ischemic stroke patients taking non-Vitamin K antagonist oral anticoagulants","volume":"48","author":"Purrucker","year":"2017","journal-title":"Stroke"},{"key":"R37-20260427","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/STROKEAHA.118.023877","article-title":"Cerebral ischemia in patients on direct oral anticoagulants","volume":"50","author":"Macha","year":"2019","journal-title":"Stroke"},{"key":"R38-20260427","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/ene.13582","article-title":"Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"25","author":"Touz\u00e9","year":"2018","journal-title":"Eur J Neurol"},{"key":"R39-20260427","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00415-018-9061-y","article-title":"Management of patients with stroke treated with direct oral anticoagulants","volume":"265","author":"Seiffge","year":"2018","journal-title":"J Neurol"},{"key":"R40-20260427","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/ene.12285","article-title":"Intravenous thrombolysis in stroke patients receiving rivaroxaban","volume":"21","author":"Seiffge","year":"2014","journal-title":"Eur J Neurol"},{"key":"R41-20260427","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/aian.AIAN_422_16","article-title":"Successful revascularization of acute middle cerebral artery occlusion by intravenous thrombolysis while on apixaban","volume":"20","author":"Nambiar","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"R42-20260427","doi-asserted-by":"crossref","first-page":"1076029624124152","DOI":"10.1177\/10760296241241524","article-title":"Challenges to laboratory monitoring of direct oral anticoagulants","volume":"30","author":"Qiao","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"key":"R43-20260427","doi-asserted-by":"crossref","first-page":"1389283","DOI":"10.3389\/fneur.2024.1389283","article-title":"Idarucizumab in dabigatran-treated patients with acute stroke: A review and clinical update","volume":"15","author":"Frol","year":"2024","journal-title":"Front Neurol"},{"key":"R44-20260427","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40265-018-0940-4","article-title":"Andexanet Alfa: First global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"R45-20260427","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/eurheartj\/ehad123","article-title":"Reversal agents for current and forthcoming direct oral anticoagulants","volume":"44","author":"Van Es","year":"2023","journal-title":"Eur Heart J"},{"key":"R46-20260427","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/aian.AIAN_536_18","article-title":"Reversal of anticoagulation effect of dabigatran with idarucizumab, for thrombolysis in acute ischemic stroke: Inimicus inimico amicus","volume":"22","author":"Maramattom","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"R47-20260427","doi-asserted-by":"crossref","first-page":"e1968","DOI":"10.1212\/WNL.0000000000009155","article-title":"Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort","volume":"94","author":"Barber","year":"2020","journal-title":"Neurology"},{"key":"R48-20260427","doi-asserted-by":"crossref","first-page":"1269651","DOI":"10.3389\/fneur.2023.1269651","article-title":"Case report: First treatment of acute ischaemic stroke in a patient on active rivaroxaban therapy using andexanet alfa and rtPA combined with early complete recovery","volume":"14","author":"Karaszewski","year":"2023","journal-title":"Front Neurol"},{"key":"R49-20260427","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/STROKEAHA.113.003806","article-title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: Comparison of prediction scores","volume":"45","author":"Strbian","year":"2014","journal-title":"Stroke"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_524_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:02:11Z","timestamp":1787839331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_524_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_524_24","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}